139 related articles for article (PubMed ID: 31229473)
1. Chemical modulation of siRNA lipophilicity for efficient delivery.
Tai W
J Control Release; 2019 Aug; 307():98-107. PubMed ID: 31229473
[TBL] [Abstract][Full Text] [Related]
2. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
3. Lipid-based nanoparticles in the systemic delivery of siRNA.
Lin Q; Chen J; Zhang Z; Zheng G
Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
[TBL] [Abstract][Full Text] [Related]
4. Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.
Shi B; Abrams M
J Histochem Cytochem; 2013 Jun; 61(6):407-20. PubMed ID: 23504369
[TBL] [Abstract][Full Text] [Related]
5. Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing.
Sarett SM; Werfel TA; Lee L; Jackson MA; Kilchrist KV; Brantley-Sieders D; Duvall CL
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6490-E6497. PubMed ID: 28739942
[TBL] [Abstract][Full Text] [Related]
6. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
[TBL] [Abstract][Full Text] [Related]
7. Targeted siRNA Delivery Using Lipid Nanoparticles.
Jorge A; Pais A; Vitorino C
Methods Mol Biol; 2020; 2059():259-283. PubMed ID: 31435927
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
Gujrati M; Vaidya A; Lu ZR
Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
[TBL] [Abstract][Full Text] [Related]
9. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
[TBL] [Abstract][Full Text] [Related]
10. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
11. Lipidic systems for in vivo siRNA delivery.
Wu SY; McMillan NA
AAPS J; 2009 Dec; 11(4):639-52. PubMed ID: 19757082
[TBL] [Abstract][Full Text] [Related]
12. Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies.
Shajari N; Mansoori B; Davudian S; Mohammadi A; Baradaran B
Curr Drug Deliv; 2017; 14(1):36-46. PubMed ID: 27538460
[TBL] [Abstract][Full Text] [Related]
13. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
14. Lipid-based siRNA Delivery Systems: Challenges, Promises and Solutions Along the Long Journey.
Sarisozen C; Salzano G; Torchilin VP
Curr Pharm Biotechnol; 2016; 17(8):728-40. PubMed ID: 27033509
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of PLGA-Lipid Hybrid Nanoparticles for siRNA Delivery Using the Emulsion Method PLGA-PEG-Lipid Nanoparticles for siRNA Delivery.
Wang L; Griffel B; Xu X
Methods Mol Biol; 2017; 1632():231-240. PubMed ID: 28730443
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
Li SD; Huang L
Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
[TBL] [Abstract][Full Text] [Related]
18. Structural modification of siRNA for efficient gene silencing.
Lee SJ; Son S; Yhee JY; Choi K; Kwon IC; Kim SH; Kim K
Biotechnol Adv; 2013; 31(5):491-503. PubMed ID: 22985697
[TBL] [Abstract][Full Text] [Related]
19. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
[TBL] [Abstract][Full Text] [Related]
20. siRNA delivery with lipid-based systems: promises and pitfalls.
Foged C
Curr Top Med Chem; 2012; 12(2):97-107. PubMed ID: 22196274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
